Petco Health and (WOOF) | Financial Analysis & Statements
Petco Health and Wellness Company Inc. Small-cap Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
1.5B
Gross Profit
580.8M
38.33%
Operating Income
31.9M
2.10%
Net Income
-2.6M
-0.17%
EPS (Diluted)
$-0.01
Balance Sheet Metrics
Total Assets
5.2B
Total Liabilities
4.0B
Shareholders Equity
1.2B
Debt to Equity
3.44
Cash Flow Metrics
Operating Cash Flow
102.1M
Free Cash Flow
116.4M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2026
Petco Health and Income Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 6.0B | 6.1B | 6.3B | 6.0B | 5.8B |
| Cost of Goods Sold | 3.7B | 3.8B | 3.9B | 3.6B | 3.4B |
| Gross Profit | 2.3B | 2.3B | 2.4B | 2.4B | 2.4B |
| Gross Margin % | 38.7% | 38.0% | 37.6% | 40.2% | 41.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 2.2B | 2.3B | 2.3B | 2.2B | 2.2B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 2.2B | 2.3B | 2.3B | 2.2B | 2.2B |
| Operating Income | 120.4M | 7.1M | 42.2M | 225.6M | 266.1M |
| Operating Margin % | 2.0% | 0.1% | 0.7% | 3.7% | 4.6% |
| Non-Operating Items | |||||
| Interest Income | 6.3M | 3.7M | 3.4M | 1.0M | 62.0K |
| Interest Expense | 131.2M | 143.5M | 150.9M | 101.6M | 77.4M |
| Other Non-Operating Income | -565.0K | 4.8M | -1.2B | -12.7M | 13.7M |
| Pre-tax Income | -5.0M | -128.0M | -1.3B | 112.3M | 202.4M |
| Income Tax | 6.3M | -7.5M | -27.6M | 35.3M | 53.5M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 31.5% | 26.4% |
| Net Income | 9.1M | -101.8M | -1.3B | 89.9M | 159.8M |
| Net Margin % | 0.2% | -1.7% | -20.5% | 1.5% | 2.8% |
| Key Metrics | |||||
| EBITDA | 323.4M | 215.3M | 251.1M | 407.8M | 473.1M |
| EPS (Basic) | $0.03 | $-0.37 | $-4.78 | $0.34 | $0.62 |
| EPS (Diluted) | $0.03 | $-0.37 | $-4.78 | $0.34 | $0.62 |
| Basic Shares Outstanding | 279555000 | 273410000 | 267549000 | 265522000 | 264261000 |
| Diluted Shares Outstanding | 279555000 | 273410000 | 267549000 | 265522000 | 264261000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Petco Health and Balance Sheet From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 256.7M | 165.8M | 125.4M | 201.9M | 211.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 45.8M | 40.4M | 44.4M | 49.6M | 55.6M |
| Inventory | 590.2M | 653.3M | 684.5M | 652.4M | 675.1M |
| Other Current Assets | 75.3M | 60.6M | 27.6M | 49.0M | 75.8M |
| Total Current Assets | 1.0B | 973.6M | 951.7M | 1.0B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.4B | 2.3B | 2.4B | 2.3B | 2.1B |
| Goodwill | 3.0B | 3.0B | 3.0B | 5.4B | 5.4B |
| Intangible Assets | 1.0B | 1.0B | 1.0B | 1.0B | 1.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 203.8M | 188.0M | 205.7M | 176.8M | 152.8M |
| Total Non-Current Assets | 4.2B | 4.2B | 4.4B | 5.6B | 5.4B |
| Total Assets | 5.2B | 5.2B | 5.4B | 6.6B | 6.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 450.6M | 492.9M | 485.1M | 381.2M | 404.0M |
| Short-term Debt | 324.7M | 311.7M | 326.5M | 332.6M | 287.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.1B | 1.1B | 1.1B | 1.0B | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.5B | 2.6B | 2.7B | 2.8B | 2.8B |
| Deferred Tax Liabilities | 234.9M | 217.7M | 251.6M | 303.1M | 318.4M |
| Other Non-Current Liabilities | 51.1M | 49.4M | 57.4M | 54.1M | 52.6M |
| Total Non-Current Liabilities | 2.9B | 2.9B | 3.1B | 3.2B | 3.2B |
| Total Liabilities | 4.0B | 4.1B | 4.2B | 4.2B | 4.2B |
| Equity | |||||
| Common Stock | 282.0K | 277.0K | 269.0K | 266.0K | 265.0K |
| Retained Earnings | -1.1B | -1.1B | -1.0B | 233.0M | 142.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.2B | 1.1B | 1.2B | 2.4B | 2.3B |
| Key Metrics | |||||
| Total Debt | 2.9B | 2.9B | 3.0B | 3.1B | 3.0B |
| Working Capital | -114.4M | -165.5M | -161.4M | -5.3M | 17.6M |
Balance Sheet Composition
Petco Health and Cash Flow Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 9.1M | -101.8M | -1.3B | 89.9M | 159.8M |
| Depreciation & Amortization | 196.7M | 199.7M | 200.8M | 193.8M | 172.4M |
| Stock-Based Compensation | 32.6M | 50.2M | 81.9M | 60.8M | 49.3M |
| Working Capital Changes | -360.4M | -382.0M | -366.9M | -383.5M | -511.6M |
| Operating Cash Flow | 294.3M | 177.5M | -935.7M | 401.6M | 263.7M |
| Investing Activities | |||||
| Capital Expenditures | -127.1M | -128.0M | -225.6M | -278.0M | -239.1M |
| Acquisitions | 0 | -629.0K | -6.7M | -44.6M | -4.3M |
| Investment Purchases | 0 | -457.0K | - | 0 | 0 |
| Investment Sales | 0 | 998.0K | 24.9M | 0 | 6.1M |
| Investing Cash Flow | -124.6M | -123.9M | -207.4M | -320.3M | -237.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 201.0M | 273.0M | 123.0M | 1.7B |
| Debt Repayment | -100.9M | -206.7M | -353.9M | -145.1M | -1.7B |
| Financing Cash Flow | -105.4M | -12.5M | -89.6M | -37.6M | -23.0M |
| Free Cash Flow | 187.0M | 49.7M | -9.9M | 68.0M | 119.1M |
| Net Change in Cash | 64.3M | 41.1M | -1.2B | 43.7M | 3.6M |
Cash Flow Trend
Petco Health and Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
99.33
Forward P/E
11.73
Price to Book
0.72
Price to Sales
0.14
PEG Ratio
-1.24
Profitability Ratios
Profit Margin
0.15%
Operating Margin
2.23%
Return on Equity
0.80%
Return on Assets
1.48%
Financial Health
Current Ratio
0.90
Debt to Equity
247.90
Beta
1.62
Per Share Data
EPS (TTM)
$0.03
Book Value per Share
$4.14
Revenue per Share
$21.33
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WOOF | 847.4M | 99.33 | 0.72 | 0.80% | 0.15% | 247.90 |
| Casey's General | 29.3B | 44.85 | 7.51 | 17.88% | 3.83% | 75.15 |
| Ulta Beauty | 25.0B | 22.22 | 8.98 | 43.60% | 9.31% | 77.84 |
| National Vision | 1.9B | 67.92 | 2.30 | 3.51% | 1.49% | 79.88 |
| Sally Beauty | 1.5B | 8.39 | 1.75 | 24.38% | 4.87% | 187.15 |
| Winmark | 1.4B | 36.16 | -30.77 | -77.59% | 48.19% | -1.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.






